engleski

Entacapone prolongs on-time in patients with Parkinson's disease

Objective:To investigate clinical efficacy of the peripheral acting COMT inhibitor entacapone during long-term study in parkinson's disease (PD) patients. Conclusion: Prolongation of the levodopa effect by entacapone is confirmed in a long-term study using a quantitative rigidity measurements for monitoring clinical response.

Entacapone; Parkinson's Disease

nije evidentirano